Purchase Order 15B61426P00000038
- Not listed
- McKesson Corporation was awarded a firm fixed-price purchase order valued at $1,596.21 by the Federal Correctional Institution at Terminal Island on July 1, 2025, with an ultimate completion date of July 28, 2025. The contract carries no set-aside designation and represents an open market procurement. The place of performance is McKesson's headquarters location in Irving, Texas. As a large business contractor, McKesson will deliver pharmaceutical products and/or medical supplies to support the...
- This federal contract is a firm fixed price purchase order awarded to McKesson Corporation by the Federal Correctional Institution Terminal Island, a civilian agency under the Department of Justice's Bureau of Prisons. The award, issued on August 7, 2025, has a ceiling value of $1,873.86 and represents an open market procurement with no set-aside designation. McKesson, a major healthcare services and pharmaceutical distribution company headquartered in Irving, Texas, will provide medical...
- McKesson Corporation, headquartered in Irving, Texas, was awarded a delivery order by the Federal Correctional Complex Tucson (a civilian facility within the Bureau of Prisons) on January 7, 2026, for pharmaceutical supplies and medications. This delivery order, valued at $2,878.01 with a firm fixed price structure and an ultimate completion date of January 31, 2026, represents a continuation of McKesson's established role as a critical pharmaceutical supplier to federal correctional facilities....
- McKesson Corporation, a prominent healthcare services and pharmaceutical distribution company headquartered in Irving, Texas, was awarded a delivery order by the Federal Correctional Institution Otisville for regular medication purchases in January 2026. The contract, valued at $150,000, operates under a firm fixed-price arrangement with no set-aside designation and carries an ultimate completion date of January 31, 2026. Performance of the contract will take place at McKesson's facility in...
- McKesson Corporation, a major healthcare services and pharmaceutical distribution provider headquartered in Irving, Texas, was awarded a delivery order valued at $1.26 million by the Federal Correctional Institution Texarkana on October 1, 2024. This firm fixed-price contract covers the provision of regular medications for the one-month period from October 1 through October 31, 2024, with a contract completion date of September 30, 2025. The award carries no set-aside designation, reflecting...
- McKesson Corporation, headquartered in Irving, Texas, was awarded a Delivery Order for pharmaceutical and medical supply materials supporting the Metropolitan Correctional Center San Diego, a civilian facility within the federal corrections system. The contract, issued on October 1, 2025, carries a ceiling value of $1,469.44 and features firm fixed-price pricing with an ultimate completion date of August 9, 2026. No small business set-aside designation was utilized for this award. This...
- McKesson Corporation, a leading healthcare services and pharmaceutical distribution company headquartered in Irving, Texas, was awarded a delivery order valued at $7,703.62 by the Federal Correctional Institution Big Spring on December 31, 2025. This firm fixed-price contract, which was not issued under any set-aside designation, calls for the delivery of controlled materials to support the correctional facility's operations. The place of performance is listed as Irving, Texas, reflecting...
- McKesson Corporation, a healthcare services and pharmaceutical distribution company headquartered in Irving, Texas, was awarded a $25,000 Delivery Order contract by the Federal Correctional Institution Tallahassee on October 1, 2025, for FY26 medication procurement. The contract utilizes firm fixed pricing with no set-aside designation and is scheduled for completion by August 31, 2026. Performance will be conducted at McKesson's location in Irving, Texas. This award represents a continuation of...
- McKesson Corporation, a leading pharmaceutical distribution and healthcare services provider headquartered in Irving, Texas, was awarded a delivery order by the Federal Correctional Complex Butner (a civilian facility under the Department of Justice) on December 1, 2024, for controlled pharmaceutical products. The contract covers two distinct performance periods: December 1–20, 2024, and December 1–March 14, 2025, with a ceiling value of $114,793.79 under firm fixed-price terms. The place of...
- McKesson Corporation, a prominent healthcare services and pharmaceutical distribution company headquartered in Irving, Texas, was awarded a purchase order valued at $3,979.03 by the Federal Correctional Complex Pollock, a civilian facility under the Federal Bureau of Prisons. The contract, awarded on September 16, 2025, with an ultimate completion date of September 30, 2025, is for pharmaceutical products to support the correctional facility's healthcare operations. This firm fixed-price...
McKesson Corporation, a major healthcare services and pharmaceutical distribution company headquartered in Irving, Texas, received a $1,124.32 firm fixed-price purchase order from the Federal Correctional Institution Terminal Island on January 1, 2026, with a completion date of September 30, 2026. This civilian contract, awarded without a small business set-aside, procures pharmaceutical supplies and medical materials essential to correctional healthcare operations. The award represents part of McKesson's extensive federal contract portfolio supporting the Department of Justice's Bureau of Prisons system, where the company serves as a critical pharmaceutical supplier across numerous correctional facilities nationwide. The purchase order is to be performed from McKesson's Irving, Texas location and leverages the company's established pharmaceutical distribution infrastructure. As a large business contractor with no set-aside designation, McKesson competes for federal opportunities across multiple agencies including the Department of Homeland Security, the Indian Health Service, and the Peace Corps. This award aligns with McKesson's primary federal engagement mechanism through contract procurement, reflecting the company's significant role in supporting federal agency pharmaceutical and medical supply chain requirements across healthcare, emergency response, and correctional operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 1/16/26 |